Global Retirement Partners’s Vaxcyte PCVX Stock Holding History

Global Retirement Partners’s Portfolio PCVX Stock Details PCVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.01K	Buy	+155	New	+$8.42K	﹤0.01%	3448
2025 Q4	$8.35K	Buy	181 +13	+8%	+$581	﹤0.01%	3227
2025 Q3	$6.05K	Hold	168	–	–	﹤0.01%	2899
2025 Q2	$5.46K	Buy	+168	New	+$5.51K	﹤0.01%	2871
2024 Q4	$1.88K	Sell	23 -10	-30%	-$993	﹤0.01%	3093
2024 Q3	$3.77K	Sell	33 -180	-85%	-$16.2K	﹤0.01%	2691
2024 Q2	$16.1K	Buy	213 +177	+492%	+$12K	﹤0.01%	2097
2024 Q1	$2.46K	Buy	36 +23	+177%	+$1.59K	﹤0.01%	2669
2023 Q4	$803	Hold	13	–	–	﹤0.01%	2957
2023 Q3	$623	Buy	+13	New	+$641	﹤0.01%	2903

Other funds holding PCVX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jupiter Topco New York $245B AUM

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Global Retirement Partners's PCVX Position: Q2 2026 in Review

Global Retirement Partners opened a new position in Vaxcyte (PCVX) in Q2 2026: 155 shares worth $9.01K. The stake represents ﹤0.01% of the portfolio and ranks #3448 among its holdings. This is a return to the name: Global Retirement Partners previously reported a position in PCVX as recently as Q4 2025.

Global Retirement Partners first reported a position in PCVX in Q3 2023 and has held it in 10 quarters since. The position peaked at $16.1K in Q2 2024. 331 funds tracked by Wall St. Rank hold PCVX as of Q2 2026.

Global Retirement Partners held 155 shares of Vaxcyte worth $9.01K as of Q2 2026.
Vaxcyte was a new Global Retirement Partners position in Q2 2026.
Vaxcyte made up ﹤0.01% of Global Retirement Partners's portfolio in Q2 2026, its #3448 holding.
Global Retirement Partners first reported a position in Vaxcyte in Q3 2023 and has held it in 10 quarters since.
Global Retirement Partners's Vaxcyte position peaked at $16.1K in Q2 2024.
331 funds tracked by Wall St. Rank held Vaxcyte as of Q2 2026.

Based on Global Retirement Partners's 13F filing for Q2 2026, filed 6 Aug 2026.